Location of Repository

DNA methylation, cell differentiation and genetic factors involved in radiosensitivity.

By George Giotopoulos


Despite its benefits in cancer treatment, ionising radiation (IR) can induce a series of adverse acute and/or long term effects. Studies on A-bomb survivors and radiotherapy patients have shown that acute whole-body exposure results in an increased risk for radiation-induced Acute Myeloid Leukaemia (r-AML), a bone marrow (BM) malignancy; whereas local-radiotherapy patients run the risk of developing acute and/or long term normal tissue reactions. Irradiated BM cells manifest persistent radiation-induced genomic instability. BM is one of the most susceptible tissues to radiation-induced cancer and one of the most radiosensitive tissues, which proposes a link between cancer susceptibility, genomic instability and radiosensitivity. The exact mechanism by which exposure of BM cells to IR leads to malignant transformation is still unclear, but the non-targeted nature of radiation-induced damage and genomic instability could suggest that an epigenetic mechanism is also involved; and DNA methylation is a good candidate. This thesis investigated genetic and epigenetic factors that may be involved in biological responses to ionising radiation exposure. Stem cell frequency is genetically determined in mouse haemopoiesis and is possibly part of the equation that defines cancer risk. Global DNA methylation levels were assessed in control haemopoietic tissues and radiation-induced leukaemias. The methylation status of haemopoietic malignancies reflects that of their untransformed tissue. Additionally, DNA methylation levels of untransformed haemopoietic tissues were found to correlate with their relative radiosensitivity in vivo. In vivo responses to ionising radiation were found to be under the influence of both genetic and epigenetic factors, highlighting the complexity of such biological reactions

Publisher: University of Leicester
Year: 2008
OAI identifier: oai:lra.le.ac.uk:2381/4150

Suggested articles



  1. (2003a) Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation-induced genomic instability and bystander effects in vitro. Radiat Res.
  2. (2003b) Non-targeted and delayed effects of exposure to ionizing radiation: II. Radiation-induced genomic instability and bystander effects in vivo, clastogenic factors and transgenerational effects. Radiat Res.
  3. (2005). A census of mammalian imprinting.
  4. (2003). A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res.
  5. (2004). A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl. Exp Hematol.
  6. (2002). A genetic determinant that specifically regulates the frequency of hematopoietic stem cells.
  7. (2007). A naturally occurring genetic variant of human XRCC2 (R188H) confers increased resistance to cisplatininduced DNA damage.
  8. (2002). A potential role for the XRCC2 R188H polymorphic site in DNAdamage repair and breast cancer. Hum Mol Genet.
  9. (2004). A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res.
  10. (2006). Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom. Clin Cancer Res.
  11. (2003). Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study.
  12. (2004). Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes.
  13. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration.
  14. (1999). Advantages of the CBA mouse in leukemogenesis research. Blood Cells Mol Dis.
  15. (2001). Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy.
  16. (2001). Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res.
  17. (2001). Allelic loss on chromosome 4 (Lyr2/TLSR5) is associated with myeloid, B-lympho-myeloid, and lymphoid (B and T) mouse radiationinduced leukemias.
  18. (1994). Alpha-particle-induced chromosomal instability in human bone marrow cells.
  19. (2001). Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity.
  20. (1982). Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells.
  21. (2001). Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res.
  22. (2001). Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma.
  23. (1988). Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes.
  24. (2003). Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res.
  25. (2003). Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients.
  26. (2001). Attenuation of radiationinduced genomic instability by free radical scavengers and cellular proliferation. Free Radic Biol Med.
  27. (2005). Autoimmune hemolytic anemia and a further example of autoanti-Kpb.
  28. (2003). Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol.
  29. Breast Cancer Trialists‟ Collaborative Group (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
  30. (2002). Cancer epigenomics.
  31. (1996). Cancer risk and oxidative DNA damage in man.
  32. (2004). CancerStats Monograph
  33. (2000). Carcinogenesis in mouse and human cells: parallels and paradoxes.
  34. (1993). Cell proliferation in normal tissues/Radiobiology of normal tissues.
  35. (1995). Cellular basis of radiation-induced fibrosis. Radiother Oncol.
  36. (1997). Cellular radiosensitivity in human severecombined-immunodeficiency (SCID) syndromes. Radiother Oncol.
  37. (1997). Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.
  38. (1995). Characterization of the truncated thrombopoietin variants.
  39. (2003). Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.
  40. (2003). Chemokines and diseases.
  41. (1996). Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
  42. (1993). Clinical manifestations of normal tissue damage.
  43. (1996). Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability.
  44. (1991). Clonal analysis of hematopoietic stem-cell differentiation in vivo.
  45. (1988). Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases.
  46. (1999). Cloning, expression and chromosome locations of the human DNMT3 gene family.
  47. (1997). Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation.
  48. (2003). Comments on the paper: Microsatellite instability in acute myelocytic leukaemia developed from A-bomb survivors--a biological perspective.
  49. (1997). Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy.
  50. (2004). Concepts of leukaemic development.
  51. (1995). Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer. Radiother Oncol.
  52. (1995). Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo.
  53. (2002). CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
  54. (2002). Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells.
  55. (2004). CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.
  56. (1990). Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine.
  57. (1999). Cytosine methylation and mammalian development. Genes Dev.
  58. (1997). Cytosine methylation and the ecology of intragenomic parasites.
  59. (2006). De novo CpG island methylation in human cancer cells. Cancer Res.
  60. (2007). De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.
  61. (1997). Delayed appearance of radiation-induced mutations at the Hprt locus in murine hemopoietic cells. Exp Hematol.
  62. (1993). Delayed chromosomal instability induced by DNA damage.
  63. (1992). Delayed reproductive death as a dominant phenotype in cell clones surviving X-irradiation.
  64. (1999). Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.
  65. (1995). Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukaemia.
  66. (1998). Difficulties using the Franco-Italian Glossary in assessing toxicity of cervical cancer treatment.
  67. (1992). Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res.
  68. (2004). Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis.
  69. (2001). DNA damage from micronutrient deficiencies is likely to be a major cause of cancer. Mutat Res.
  70. (1988). DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Prog Nucleic Acid Res Mol Biol.
  71. (2000). DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet.
  72. (1998). DNA hypomethylation leads to elevated mutation rates.
  73. (1998). DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro.
  74. (2006). DNA methylation during mouse hemopoietic differentiation and radiationinduced leukemia. Exp Hematol.
  75. (2002). DNA methylation in cancer: too much, but also too little.
  76. (2000). DNA methylation in health and disease.
  77. (2001). DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet.
  78. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
  79. (1995). DNA repair and mutagenesis, 1 st edition. Washington DC, ASM press.
  80. (2002). DNA repair capacity after gamma-irradiation and expression profiles of DNA repair genes in resting and proliferating human peripheral blood lymphocytes.
  81. (2004). Dnmt1 expression in pre- and postimplantation embryogenesis and the maintenance of IAP silencing.
  82. (2002). Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it? Radiother Oncol.
  83. (2004). Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes.
  84. (2005). Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes. Breast Cancer Res.
  85. (1998). Effects of X-ray irradiation on genomic DNA methylation levels in mouse tissues.
  86. (2002). Elevated mutation rates in the germ line of first- and second-generation offspring of irradiated male mice.
  87. (1991). Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule.
  88. (1995). EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol.
  89. (2002). Epidemiologic studies of folate and colorectal neoplasia: a review.
  90. (2005). Eukaryotic cytosine methyltransferases. Annu Rev Biochem.
  91. (2001). European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups.
  92. (1999). Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children.
  93. (2005). Evidence for a gene influencing haematocrit on chromosome 6q23-24: genome wide scan in the Framingham Heart Study.
  94. (1992). Evidence that hematopoietic stem cells express mouse ckit but do not depend on steel factor for their generation.
  95. (1995). Expression of transforming growth factor-beta 1 in mouse skin during the acute phase of radiation damage.
  96. (2003). Expression of various genes is controlled by DNA methylation during mammalian development.
  97. (2001). Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly.
  98. (1997). Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage.
  99. (2003). Folate status, metabolic genotype, and biomarkers of genotoxicity in healthy subjects.
  100. (2004). Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen.
  101. (1999). Folic acid deficiency and cancer: mechanisms of DNA instability.
  102. (2000). Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol.
  103. (2000). Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res.
  104. (2003). Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect.
  105. (2004). Genetic analysis of macrophage characteristics as a tool to identify tumor susceptibility genes: mapping of three macrophage-associated risk inflammatory factors, marif1, marif2, and marif3. Cancer Res.
  106. (2005). Genetic and epigenetic factors in mouse radiation induced leukaemogenesis.
  107. (1999). Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet.
  108. (1996). Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1.
  109. (1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.
  110. (1997). Genetic factors influencing alpha-particle-induced chromosomal instability.
  111. (1998). Genetic instability in radiation-induced leukaemias: mouse models.
  112. (1993). Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.
  113. (1997). Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease.
  114. (2002). Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities.
  115. (2000). Genetic regulation of anti-erythrocyte autoantibodies and splenomegaly in autoimmune hemolytic anemia-prone new zealand black mice. Int Immunol.
  116. (2002). Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen.
  117. (2006). Genetic Susceptibility to Radiation-Induced Acute Myeloid Leukaemia (r-AML).
  118. (2002). Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines.
  119. (2001). Genome maintenance mechanisms for preventing cancer.
  120. (2003). Genomic approaches to identification of tumoursusceptibility genes using mouse models. Curr Opin Genet Dev.
  121. (2003). Genomic instability and radiation.
  122. (1998). Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation.
  123. (2000). Geriatric Oncology: Challenges for the new century.
  124. (2007). Health effects in those with acute radiation sickness from the Chernobyl accident. Health Phys.
  125. (2002). Hematologic consequences of exposure to ionizing radiation. Exp Hematol.
  126. (1999). Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer?
  127. (2000). Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay.
  128. (2008). Histone modifications and Epigenetics.
  129. (2000). Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome. Mutat Res.
  130. (1998). Hypomethylation of pericentromeric DNA in breast adenocarcinomas.
  131. (2001). Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells.
  132. (2004). Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays.
  133. (2006). Identification of quantitative trait loci regulating haematopoietic parameters in B6AKRF2 mice.
  134. (1998). Impact of genomic imprinting on genomic instability and radiation-induced mutation.
  135. (1992). In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells.
  136. (2001). In vivo chromosomal instability and transmissible aberrations in the progeny of haemopoietic stem cells induced by high- and low-LET radiations.
  137. (1999). In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells.
  138. (2003). Increased folate catabolism following total body gamma-irradiation in mice.
  139. (1997). Increased sensitivity of scid heterozygous mice to ionizing radiation.
  140. (2003). Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol.
  141. (2003). Induction of tumors in mice by genomic hypomethylation.
  142. (1988). Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma.
  143. (1997). Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene.
  144. (1997). Introduction to the cellular and molecular biology of human cancer, 3 rd edition.
  145. (1993). Introduction: The significance of radiobiology for radiotherapy.
  146. (1998). Ionizing radiation and cancer risk: evidence from epidemiology. Radiat Res.
  147. (2003). Irradiation of dystrophic host tissue prior to myoblast transfer therapy enhances initial (but not long-term) survival of donor myoblasts.
  148. (2006). L1 retrotransposons in human cancers.
  149. (2005). Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study.
  150. (2006). Large-scale structure of genomic methylation patterns. Genome Res.
  151. (2003). Late radiation-related fibrosis: pathogenesis, manifestations, and current management. Semin Radiat Oncol.
  152. (1997). Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation.
  153. (1996). Leukemia following low-dose total body irradiation and chemotherapy for nonHodgkin's lymphoma.
  154. (2002). Little evidence for developmental plasticity of adult hematopoietic stem cells.
  155. (1996). Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation.
  156. (1996). Long-term in vivo transmission of alphaparticle-induced chromosomal instability in murine haemopoietic cells.
  157. (2003). Low-penetrance genetic susceptibility and resistance loci implicated in the relative risk for radiationinduced acute myeloid leukemia in mice.
  158. (1997). Mapping genes controlling hematocrit in the spontaneously hypertensive rat. Mamm Genome.
  159. (2003). Measuring postirradiation subcutaneous soft-tissue fibrosis: state-of-the-art and future directions. Semin Radiat Oncol.
  160. (2004). Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L.
  161. (2004). Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. Mutat Res.
  162. (1992). Methylation patterns of long interspersed repeated DNA and alphoid repetitive DNA from human cell lines and tumors. Anticancer Res.
  163. (2005). Microsatellite polymorphisms in DNA repair genes XRCC1, XRCC3 and XRCC5 in patients with gynecological tumors: association with late clinical radiosensitivity and cancer incidence. Radiat Res.
  164. (2004). Mobile elements: drivers of genome evolution.
  165. (2007). Mouse bone marrow and peripheral blood erythroid cell counts are regulated by different autosomal genetic loci. Blood Cells Mol Dis.
  166. (2006). Mouse models of XRCC1 DNA repair polymorphisms and cancer.
  167. (1993). Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells.
  168. (1995). Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida.
  169. (2002). Myeloid, B and T lymphoid and mixed lineage Thymic lymphomas in the irradiated mouse.
  170. (2004). New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy?
  171. (2005). Normal and leukaemic stem cells.
  172. (2003). Normal tissue effects: reporting and analysis.
  173. (1990). Nutritional folate-deficiency in Chinese hamster ovary cells. Chromosomal abnormalities associated with perturbations in nucleic acid precursors. Cancer Genet Cytogenetic.
  174. (2008). Ontogeny of erythropoiesis in the mammalian embryo. Curr Top Dev Biol.
  175. (1994). Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. Semin Radiat Oncol.
  176. (1998). Peripheral blood CD34+ cell count reliably predicts autograft yield. Bone Marrow Transplant.
  177. (1996). Persistent expression of morphological abnormalities in the distant progeny of irradiated cells. Radiat Environ Biophys.
  178. (1997). Pitfalls in the use of several "housekeeping" genes as standards for quantitation of mRNA: the example of thyroid cells.
  179. (2003). Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.
  180. (2007). Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer.
  181. (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev.
  182. (2004). Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review.
  183. (2006). Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy-related acute myeloid leukemia.
  184. (2003). Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev.
  185. (2003). Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol.
  186. (2006). Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer.
  187. (1996). Profiles of non-cancer diseases in atomic bomb survivors. World Health Stat Q.
  188. (2003). Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg. Clin Immunol.
  189. (1988). Purification and characterisation of mouse hematopoietic stem cells.
  190. (2008). QTL analyses of lineage-negative mouse bone marrow cells labelled with Sca-1 and c-Kit. Mamm Genome.
  191. (1990). Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy.
  192. (2004). Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice.
  193. (2004). Quantitative trait loci for steady-state platelet count in mice.
  194. (2002). Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood.
  195. (2004). Radiation and cardiovascular diseases.
  196. (1995). Radiation inhibition of mdx mouse muscle regeneration: dose and age factors. Muscle Nerve.
  197. (2007). Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?
  198. (2008). Radiation-induced cardiovascular injury. Radiat Environ Biophys.
  199. (1997). Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white. Radiat Res.
  200. (1999). Radiation-induced cytogenetic instability in vivo. Radiat Res.
  201. (2005). Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.
  202. (2003). Radiation-induced DNA damage and repair in lymphocytes from breast cancer patients and their correlation with acute skin reactions to radiotherapy.
  203. (2007). Radiation-induced DNA damage as a predictor of longterm toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy. Radiat Res.
  204. (2003). Radiation-induced genomic instability and bystander effects: inter-related nontargeted effects of exposure to ionizing radiation.
  205. (2006). Radiation-induced transgenerational alterations in genome stability and DNA damage.
  206. (1996). Radiationinduced genomic instability and persisting oxidative stress in primary bone marrow cultures.
  207. (2002). Radiosensitivity in Fanconi's anaemia patients. Radiother Oncol.
  208. (1997). Regeneration-blocked mdx muscle: in vivo model for testing treatments. Muscle Nerve.
  209. (1999). Requirement for the Xrcc1 DNA base excision repair gene during early mouse development.
  210. (2004). Retrotransposition of limited deletion type of intracisternal A-particle elements in the myeloid leukemia Clls of C3H/He mice.
  211. (2000). Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res.
  212. (2006). Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples.
  213. (1999). Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutat Res.
  214. (1991). Scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA doublestrand break repair.
  215. (1992). Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow.
  216. (2006). Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers.
  217. (2004). Sex- and tissue-specific expression of maintenance and de novo DNA methyltransferases upon low dose Xirradiation in mice.
  218. (2006). SLAM family markers are conserved among hematopoietic stem cells from old and reconstituted mice and markedly increase their purity.
  219. (2005). SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.
  220. (2005). Stable loss of global DNA methylation in the radiation-target tissue--a possible mechanism contributing to radiation carcinogenesis?
  221. (2003). Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950–1997. Radiat Res.
  222. (1996). Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res.
  223. (1999). Studies of the mortality of atomic bomb survivors. Report 12, part II. Noncancer mortality: 1950-1990. Radiat Res.
  224. (1990). Synergistic interactions allow colony formation in vitro by murine haemopoietic stem cells. Leuk Res.
  225. (2007). Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis.
  226. (1987). Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development.
  227. (2000). TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target?
  228. (1999). TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing postradiotherapy fibrosis.
  229. (2005). TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol.
  230. (2003). The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res.
  231. (2008). The Biology of Genomic Imprinting.
  232. (2004). The cancer epidemiology of radiation.
  233. (2004). The cell surface receptor SLAM controls T cell and macrophage functions.
  234. (2007). The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.
  235. (2000). The DNA methyltransferases of mammals.
  236. (2008). The Dynamic Epigenome:
  237. (1989). The effect of gamma radiation on DNA methylation. Radiat Res.
  238. (2007). The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit Rev Clin Lab Sci.
  239. (2006). The epigenetic progenitor origin of human cancer.
  240. (2007). The epigenomics of cancer.
  241. (1999). The erythropoietin receptor.
  242. (2002). The fundamental role of epigenetic events in cancer.
  243. (2001). The genetic structure of recombinant inbred mice: high-resolution consensus maps for complex trait analysis.
  244. (1999). The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors.
  245. (2004). The human genome project and the discovery of genetic determinants of cancer susceptibility.
  246. (1998). The impact of L1 retrotransposons on the human genome.
  247. (1999). The incidence of secondary leukemias.
  248. (2007). The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes.
  249. (1996). The new biology of leukaemia.
  250. (2001). The Oxford Textbook of Oncology, 2 nd edition.
  251. (1996). The p53 response to ionising radiation in adult and developing murine tissues.
  252. (2000). The Physics and chemistry of Radiation absorption/DNA Strand breaks and Chromosomal Aberrations.
  253. (2006). The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma.
  254. (2001). The role of folic acid and Vitamin B12 in genomic stability of human cells.
  255. (2006). The role of mesenchymal stem cells in haemopoiesis. Blood Rev.
  256. (2004). The XRCC genes: expanding roles in DNA doublestrand break repair.
  257. (1998). The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family. Nucleic Acids Res.
  258. (1983). Tissue-specific differences in DNA methylation in various mammals.
  259. (2003). Tissue-specific p53 responses to ionizing radiation and their genetic modification: the key to tissue-specific tumour susceptibility?
  260. (1995). Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).
  261. (2003). Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia.
  262. (2000). Transgenerational mutation by radiation.
  263. (1992). Transmission of chromosomal instability after plutonium alpha-particle irradiation.
  264. (2003). Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
  265. (1998). Trial Standardisation of Breast Radiotherapy. Clinical Trials and Statistics Unit.
  266. (1989). Two phases of engraftment established by serial bone marrow transplantation in mice.
  267. (2008). X Chromosome Inactivation.
  268. (2005). XRCC1 is required for DNA single-strand break repair in human cells.
  269. (2005). XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev.
  270. (2002). XRCC2 is Required for the Formation of Rad51 Foci Induced by Ionizing Radiation and DNA Cross-Linking Agent Mitomycin C.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.